Structural formula: Lidocaine

XYLONOR, 150 mg/1.5 mg per g, solution as an oromucosal spray bottle, 36 g

Telegram WhatsApp

Link to share

Active ingredients: CÉTRIMIDE, Lidocaine

Commercialized according to BDPMDispensing in France: Prescription only

Solution for sprayingbottle, 36 ggingivale

No current ANSM shortage notice is included

Package details

Original BDPM fields are shown in French.

Official name: XYLONOR, 150 mg/1,5 mg par g, solution pour pulvérisation buccale
Pharmaceutical form: solution pour pulvérisation
Route of administration: gingivale
Presentation description: 1 flacon(s) pulvérisateur(s) en verre de 36 g avec pompe doseuse et avec embout polyéthylène
Marketing authorisation holder: SEPTODONT
Reimbursement according to BDPM: —
Approval for use in healthcare institutions: oui
Commercialization declaration date: 31 Dec 1997
Prescription and dispensing conditions: Prescription only
List II: prescription-only medicine
For professional use only
Original BDPM wording: liste II · réservé à l'usage professionnel selon l'article R.5121-80 du code de la santé publique
Enhanced ANSM monitoring: No

BDPM identifiers

CIS66081953CIP73175326CIP133400931753261

Composition in BDPM

Composition in BDPM
Component	Amount per unit	Source type
LIDOCAÏNEsolution	15,00 g · 100 g de solution à usage dentaire	SA
CÉTRIMIDEsolution	0,15 g · 100 g de solution à usage dentaire	SA

Information is based on BDPM data and is for reference only. Consult a doctor before use.

Similar medicines

Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.

The current BDPM data does not list similar medicines for this product.